Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Monday, October 1, 2007

A meta-analysis of 8 randomized controlled trials reports that, overall, folic acid supplementation reduced the risk for a first stroke by 18%. The stroke risk reduction was about 25% in subgroups that received supplements for more than 3 years, had blood homocysteine levels that decreased by 20% or more, or lived in regions with no folate grain fortification. There was no significant risk reduction in the corresponding subgroups without these characteristics. Although these data appear promising, experts caution that further randomized studies are needed before folic acid can be recommended for primary prevention of stroke.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues